Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR+157.8%
5Y CAGR+7.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+157.8%/yr
vs -48.5%/yr prior
5Y CAGR
+7.5%/yr
Recent acceleration
Acceleration
+206.2pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $258515.00 | -40.8% |
| 2024 | $437010.00 | -18.9% |
| 2023 | $539158.00 | +3473.2% |
| 2022 | $15089.00 | +100.6% |
| 2021 | $-2.40M | -1435.7% |
| 2020 | $179742.00 | -83.7% |
| 2019 | $1.10M | +415.1% |
| 2018 | $213723.00 | -57.1% |
| 2017 | $497865.00 | -91.8% |
| 2016 | $6.04M | - |